Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience [0.03%]
非小细胞肺癌组织PD-L1检测22C3抗体的临床意义：单中心经验报道
Maiko Takeda,Takahiko Kasai,Maiko Naito et al.
Maiko Takeda et al.
Background: In recent years, the anti-programmed cell death 1 (PD-1) drug pembrolizumab (Keytruda) was approved for treatment of unresectable advanced non-small cell lung cancer (NSCLC) as first- or second-line therapy de...
Correlation Between the Sites of Onset of Basal Cell Carcinoma and the Embryonic Fusion Planes in the Auricle [0.03%]
耳廓基底细胞癌发生部位与胚胎融合线的关系研究
Giovanni Nicoletti,Marco Mario Tresoldi,Alberto Malovini et al.
Giovanni Nicoletti et al.
Objectives: This study aims at the identification of the distribution of basal cell carcinomas (BCCs) in the auricle in correlation with the currently most credited sites of the embryonic fusion planes of the auricle. ...
A Rare Primary Tumor of the Thyroid Gland: A New Case of Leiomyoma and Literature Review [0.03%]
甲状腺原发性平滑肌瘤一例及文献复习
Yanling Zhang,Heng Tang,Huaiyuan Hu et al.
Yanling Zhang et al.
Primary leiomyomas of the thyroid are very rare. We here report a case of a 53-year-old woman with a painless mass at the right thyroid, revealed by physical examination. The patient underwent a lobectomy. Frozen sections showed a spindle c...
A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status [0.03%]
单中心不明BRCA状态的三阴性乳腺癌患者辅助化疗方案中加入顺铂的经验分析
Ying-Wen Su,Chia-Yen Hung,Hung-Bun Lam et al.
Ying-Wen Su et al.
The clinical benefit of adding platinum to adjuvant chemotherapy for patients with triple-negative breast cancer (TNBC) has not been well investigated, although it was associated an improved response rate in neoadjuvant setting. We retrospe...
Early Clinical Outcomes, Patterns of Failure, and Acute Haematologic Toxicity of Image-Guided Volumetric Modulated Arc Therapy (IG-VMAT) in the Definitive Treatment of Locally Advanced Carcinoma Cervix [0.03%]
图像引导容积旋转调强放疗(IG-VMAT)根治性治疗局部晚期宫颈癌早期临床疗效、失败模式及急性血液学毒性分析
Irfan Ahmad,Kundan Singh Chufal,Irfan Bashir et al.
Irfan Ahmad et al.
Purpose: To evaluate clinical outcomes and failure patterns in patients with locally advanced cervical cancer (LACC) treated definitively using image-guided volumetric-modulated arc therapy (IG-VMAT). ...
Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort [0.03%]
一项巴西队列的三阴性与非三阴性乳腺癌生存研究
Homero Gonçalves Jr,Maximiliano Ribeiro Guerra,Jane Rocha Duarte Cintra et al.
Homero Gonçalves Jr et al.
Objective: To analyze the clinical, pathological, and sociodemographic aspects between triple-negative breast cancer (TNBC) and non-TNBC in a Brazilian cohort and identify potential prognostic factors. ...
Identifying Risk Factors for Morbidity and Mortality in Patients with Primary Head and Neck Cancers in a Nigerian Population [0.03%]
尼日利亚头颈肿瘤患者发病率和死亡率危险因素识别
Adeyi A Adoga,John P Yaro,Joyce G Mugu et al.
Adeyi A Adoga et al.
Background: The risk factors for head and neck cancers (HNC) vary in different parts of the world. Objectives: To identify the risk fac...
Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience [0.03%]
印度患者接受尔必杜作为二线或以上化疗治疗转移性乳腺癌的前瞻性分析
B J Srinivasa,Bhanu Prakash Lalkota,Girish Badarke et al.
B J Srinivasa et al.
Background: Eribulin mesylate is a non-taxane microtubule inhibitor which can be used after anthracycline and taxane treatment in patients with metastatic breast cancer (MBC). The purpose of this study was to investigate ...
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach [0.03%]
子宫腺肉瘤的综合序列治疗经验报告一篇基于单一中心的临床报道
Margherita Nannini,Giulia Dondi,Donatella Santini et al.
Margherita Nannini et al.
Adenosarcomas are the rarest form of uterine sarcomas, and clinical experience with their management is still limited. Here, we reported 7 patients with uterine adenosarcoma referred to our institution, focusing on main pathologic features,...